Skip to main content
. 2008 Oct 23;17(12):1714–1720. doi: 10.1007/s00586-008-0805-8

Table 4.

Differences in scar score compared with VAS score, in control- and ADCON-L treated groups at 24 months

Scar score 0 1 2 3–4
ADCON-L 6.9% (4) 48.3% (28) 37.9% (22) 6.9% (4) 100% (58)
VAS leg pain (median, range) 34 (0–68) 19 (0–79) 22 (0–95) 17 (9–65)
Controls 15.6% (7) 35.6% (16) 35.6% (16) 13.3% (6) 100% (45)
VAS leg pain (median, range) 21 (0–41) 14 (0–52) 25 (0–90) 37 (10–79)